Award from Barth Syndrome Foundation

Congratulations to Douglas Strathdee, Head of Transgenic Technology at the Beatson, who has been awarded almost $50,000 over two years by the Barth Syndrome Foundation to develop an accurate in vivo model of Barth Syndrome. This rare X-linked genetic disease is characterised by cardiomyopathy, growth delay, muscle hypoplasia, neutropenia and extreme fatigue. More details of the project can be found here.


At the bench 3 160

Read more about the Research Groups working at the Beatson Institute.



Running a gel 154

Find out more about our seminars including our Distinguished Seminar Programme.